| For: | Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15(37): 4666-4674 [PMID: 19787830 DOI: 10.3748/wjg.15.4666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i37/4666.htm |
| Number | Citing Articles |
| 1 |
Aditi Kumar, Matthew J. Brookes. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020; 12(11) doi: 10.3390/nu12113478
|
| 2 |
Michael Auerbach, Harold Ballard. Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety. Hematology 2010; 2010(1) doi: 10.1182/asheducation-2010.1.338
|
| 3 |
Bhavesh S. Barot, Punit B. Parejiya, Pragna K. Shelat, Gaurang B. Shah, Dharmik M. Mehta, Trupti V. Pathak. Physicochemical and toxicological characterization of sucrose-bound polynuclear iron oxyhydroxide formulations. Journal of Pharmaceutical Investigation 2015; 45(1) doi: 10.1007/s40005-014-0143-2
|
| 4 |
Rahul P Patel, Troy Wanandy, Serena Loring, Cameron Johns, Joseph Hutchinson, Madhur Shastri. Stability of Diluted Iron Polymaltose in PVC Infusion Bags. Journal of Pharmacy Practice and Research 2013; 43(2) doi: 10.1002/j.2055-2335.2013.tb00232.x
|
| 5 |
Walter Reinisch, Michael Staun, Sunil Bhandari, Manuel Muñoz. State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7(6) doi: 10.1016/j.crohns.2012.07.031
|
| 6 |
Jaya Chaturvedi, Rupendra K, Anupama Bahadur, Ayush Heda, Rajlaxmi Mundhra. Comparative analysis of ferric carboxymaltose and iron sucrose in treating iron deficiency anemia in perimenopausal women with heavy menstrual bleeding: a randomized controlled trial. Obstetrics & Gynecology Science 2024; 67(6) doi: 10.5468/ogs.24065
|
| 7 |
Kyeong Ok Kim. Management of Anemia in Patients with Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2015; 65(3) doi: 10.4166/kjg.2015.65.3.145
|
| 8 |
RODOLFO D. CANÇADO, MANUEL MUÑOZ. Iron replacement options: oral and intravenous formulations. Transfusion Alternatives in Transfusion Medicine 2012; 12(3-4) doi: 10.1111/j.1778-428X.2012.01178.x
|
| 9 |
Elpis Mantadakis. Advances in Pediatric Intravenous Iron Therapy. Pediatric Blood & Cancer 2016; 63(1) doi: 10.1002/pbc.25752
|
| 10 |
Fernando Gomollón, Javier P. Gisbert, José Antonio García-Erce. Intravenous iron in digestive diseases: a clinical (re)view. Therapeutic Advances in Chronic Disease 2010; 1(2) doi: 10.1177/2040622310373675
|
| 11 |
Fermín Mearin, Agustín Balboa, Antoni Castells, J. Enrique Domínguez, Maria Esteve, Jose A. García-Erce, Javier Pérez Gisbert, Fernando Gomollón, Julián Panés, Julio Ponce. Anemia ferropénica y uso de hierro endovenoso en patología digestiva. Gastroenterología y Hepatología 2010; 33(8) doi: 10.1016/j.gastrohep.2010.08.001
|
| 12 |
M. A. Abounassif, M. A. Al‐Omar, A.‐G. E. Amr, G. A. E. Mostafa. PVC membrane sensor for potentiometric determination of iron (II) in some pharmaceutical formulations based on a new neutral ionophore. Drug Testing and Analysis 2011; 3(6) doi: 10.1002/dta.231
|
| 13 |
Sergey K. Zyryanov, Elena A. Baybulatova. Selection of parenteral iron supplement for iron deficiency anemia: A review. Terapevticheskii arkhiv 2024; 96(4) doi: 10.26442/00403660.2024.04.202693
|
| 14 |
Cem Çekiç, Serkan İpek, Fatih Aslan, Zehra Akpınar, Mahmut Arabul, Firdevs Topal, Elif Sarıtaş Yüksel, Emrah Alper, Belkıs Ünsal. The Effect of Intravenous Iron Treatment on Quality of Life in Inflammatory Bowel Disease Patients with Nonanemic Iron Deficiency. Gastroenterology Research and Practice 2015; 2015 doi: 10.1155/2015/582163
|
| 15 |
Mayura Thilanka Iddagoda, Christopher Etherton-Beer, Leon Flicker. Role of intravenous iron therapy for management of perioperative anaemia: A narrative review. Perioperative Precision Medicine 2024; doi: 10.61189/956852bomilz
|
| 16 |
Walter Reinisch, Istvan Altorjay, Ferenc Zsigmond, Christian Primas, Harald Vogelsang, Gottfried Novacek, Sieglinde Reinisch, Lars L. Thomsen. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015; 50(10) doi: 10.3109/00365521.2015.1031168
|
| 17 |
W. Reinisch, Y. Chowers, S. Danese, A. Dignass, F. Gomollón, O. Haagen Nielsen, P. L. Lakatos, C. W. Lees, S. Lindgren, M. Lukas, G. J. Mantzaris, P. Michetti, B. Moum, L. Peyrin-Biroulet, M. Toruner, J. van der Woude, G. Weiss, H. Stoevelaar. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method. Alimentary Pharmacology & Therapeutics 2013; 38(9) doi: 10.1111/apt.12493
|
| 18 |
Kevin T. Lynch, Taryn E. Hassinger. Preoperative Identification and Management of Anemia in the Colorectal Surgery Patient. Clinics in Colon and Rectal Surgery 2023; 36(03) doi: 10.1055/s-0043-1760868
|
| 19 |
Eboselume Akhuemonkhan, Alyssa Parian, Kathryn A Carson, Susan Hutfless. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010–2014. Inflammatory Bowel Diseases 2018; 24(8) doi: 10.1093/ibd/izy063
|
| 20 |
Markus R. Jahn, Hans B. Andreasen, Sören Fütterer, Thomas Nawroth, Volker Schünemann, Ute Kolb, Wolfgang Hofmeister, Manuel Muñoz, Klaus Bock, Morten Meldal, Peter Langguth. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications. European Journal of Pharmaceutics and Biopharmaceutics 2011; 78(3) doi: 10.1016/j.ejpb.2011.03.016
|
| 21 |
|
| 22 |
Angelina Dosal, Xavier Calvet, Laura Moreno, María López, Ariadna Figuerola, Miquel Ángel Ruíz, David Suárez, Emili Gené, Mireia Miquel, Albert Villoria. Uso del hierro intravenoso en un hospital de día de aparato digestivo: indicaciones, dosificación y efectos adversos. Gastroenterología y Hepatología 2010; 33(7) doi: 10.1016/j.gastrohep.2010.02.011
|
| 23 |
FERNANDO GOMOLLÓN, JAVIER P. GISBERT. Intravenous iron in digestive diseases. Transfusion Alternatives in Transfusion Medicine 2012; 12(3-4) doi: 10.1111/j.1778-428X.2012.01170.x
|
| 24 |
Lucia Cococcioni, Licia Pensabene, Sara El-Khouly, Sibongile Chadokufa, Sara McCartney, Efstratios Saliakellis, Fevronia Kiparissi, Osvaldo Borrelli. Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia. Digestive and Liver Disease 2021; 53(7) doi: 10.1016/j.dld.2021.02.017
|
| 25 |
Reddikumar Reddy Galigutta, Christy Thomas, Mahesh Rathod, P. N. Hasik, R. S. Ray, Jai Prakash, Krishna Undela. Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports. European Journal of Clinical Pharmacology 2025; 81(7) doi: 10.1007/s00228-025-03849-z
|
| 26 |
Agustín Urrutia, Emilio Sacanella, Jordi Mascaro, Francesc Formiga. Anemia en el anciano. Revista Española de Geriatría y Gerontología 2010; 45(5) doi: 10.1016/j.regg.2010.06.003
|
| 27 |
Anthony E. Wiskin, Ben J. Fleming, Stephen A. Wootton, R. Mark Beattie. Anaemia and iron deficiency in children with inflammatory bowel disease. Journal of Crohn's and Colitis 2012; 6(6) doi: 10.1016/j.crohns.2011.12.001
|
| 28 |
Chen Yueying, Wang Yu Fan, Shen Jun. Anemia and iron deficiency in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2020; 14(3) doi: 10.1080/17474124.2020.1732817
|
| 29 |
E. O. Kurilovich, O. I. Volkova, L. D. Popovich. Clinical and economic aspects of the use of parenteral iron preparations for the correction of iron deficiency and anemia in surgical patients. Glavvrač (Chief Medical Officer) 2020; (12) doi: 10.33920/med-03-2012-04
|
| 30 |
Basim S Alharbi, Bashair Z Alqaidi, Fouad S Alharbi, Ahmed M Alharbi, Mohammed S Alsharif. Comparing the Efficacy of Intravenous Versus Oral Iron Supplementation for Anemic Patients With Inflammatory Bowel Disease: A Meta-Analysis. Cureus 2025; doi: 10.7759/cureus.97917
|
| 31 |
G. Barragán-Ibañez, A. Santoyo-Sánchez, C.O. Ramos-Peñafiel. Iron deficiency anaemia. Revista Médica del Hospital General de México 2016; 79(2) doi: 10.1016/j.hgmx.2015.06.008
|
| 32 |
Yash Shah, Dhruvan Patel, Nabeel Khan. Iron deficiency anemia in IBD: an overlooked comorbidity. Expert Review of Gastroenterology & Hepatology 2021; 15(7) doi: 10.1080/17474124.2021.1900730
|
| 33 |
Hee-Sun Park, Tae-Yop Kim, Ha-Jung Kim, Young-Jin Ro, Hwa-Young Jang, Won Uk Koh. The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial. Journal of Clinical Medicine 2019; 8(10) doi: 10.3390/jcm8101674
|
| 34 |
Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente, Gian Luigi Gigli. ADMET considerations for restless leg syndrome drug treatments. Expert Opinion on Drug Metabolism & Toxicology 2012; 8(10) doi: 10.1517/17425255.2012.708023
|
| 35 |
Reeta Mahey, Alka Kriplani, Krishna D. Mogili, Neerja Bhatla, Garima Kachhawa, Renu Saxena. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding. International Journal of Gynecology & Obstetrics 2016; 133(1) doi: 10.1016/j.ijgo.2015.09.007
|
| 36 |
Dorothea Niepel, Thomas Klag, Nisar P. Malek, Jan Wehkamp. Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818769074
|
| 37 |
Guy Rostoker, Nosratola D. Vaziri. Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations. Heliyon 2019; 5(7) doi: 10.1016/j.heliyon.2019.e02045
|
| 38 |
José Antonio García-Erce, Manuel Quintana Díaz, Manuel Muñoz Gómez. Transfusión y anticoagulación en el manejo de la hemorragia digestiva alta no varicosa en España. Gastroenterología y Hepatología 2013; 36(2) doi: 10.1016/j.gastrohep.2012.09.004
|
| 39 |
Sanghoon Lee, Ki‐Jin Ryu, Eun Sil Lee, Keun Ho Lee, Jeong Jae Lee, Tak Kim. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open‐label, multicenter, randomized study. Journal of Obstetrics and Gynaecology Research 2019; 45(4) doi: 10.1111/jog.13893
|
| 40 |
Rayan Bou-Fakhredin, Racha Halawi, Joseph Roumi, Ali Taher. Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease. Expert Review of Hematology 2017; 10(9) doi: 10.1080/17474086.2017.1355233
|
| 41 |
S. Bhandari. Beyond efficacy and safety--the need for convenient and cost-effective iron therapy in health care. Clinical Kidney Journal 2011; 4(suppl 1) doi: 10.1093/ndtplus/sfr044
|
| 42 |
João Ricardo Friedrisch, Rodolfo Delfini Cançado. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Revista Brasileira de Hematologia e Hemoterapia 2015; 37(6) doi: 10.1016/j.bjhh.2015.08.012
|
| 43 |
Mirela Țigliș, Tiberiu Paul Neagu, Andrei Niculae, Ioan Lascăr, Ioana Marina Grințescu. Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods. Medicina 2020; 56(10) doi: 10.3390/medicina56100528
|